Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.

Vaz-Salgado MÁ, Del Barco S, Sepúlveda JM, Alonso M, Pineda E, Balana C, Martínez-García M, Gironés R

Open source

DOI
10.1038/s41467-025-66747-z
Published
2025 Dec 4
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-025-66747-z,
  title = {Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.},
  author = {Vaz-Salgado MÁ and Del Barco S and Sepúlveda JM and Alonso M and Pineda E and Balana C and Martínez-García M and Gironés R},
  year = {2025},
  journal = {Nature communications},
  doi = {10.1038/s41467-025-66747-z},
  url = {https://doi.org/10.1038/s41467-025-66747-z}
}

RIS

TY  - JOUR
TI  - Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.
AU  - Vaz-Salgado MÁ
AU  - Del Barco S
AU  - Sepúlveda JM
AU  - Alonso M
AU  - Pineda E
AU  - Balana C
AU  - Martínez-García M
AU  - Gironés R
PY  - 2025
JO  - Nature communications
DO  - 10.1038/s41467-025-66747-z
UR  - https://doi.org/10.1038/s41467-025-66747-z
ER  - 

APA

MÁ, V., S, D. B., JM, S., M, A., E, P., C, B., M, M., & R, G. (2025). Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial.. Nature communications. https://doi.org/10.1038/s41467-025-66747-z

Source records